Overexpression of citrate synthase in cardiomyocytes was found to reduce susceptibility to AF and atrial remodeling in mice, accompanied by enhanced ATP production, upregulation of mitochondrial oxidative phosphorylation complexes I–V, and reduced oxidative stress. The gene discussed is CS; the disease is atrial fibrillation.